FDA全球物质注册数据库(FDA Global Substance Registration System)
检索条件:" RN=2231068-83-8"
物质名称 CAS登记号 物质唯一标识 分子式 异名/同义词
FAVEZELIMAB 2231068-83-8 H1396W7D1H ANTI-LAG3 MONOCLONAL ANTIBODY MK-4280
FAVEZELIMAB
FAVEZELIMAB [INN]
FAVEZELIMAB [USAN]
FAVEZELIMAB [WHO-DD]
IMMUNOGLOBULIN G4 (227-PROLINE), ANTI-(HUMAN LYMPHOCYTE ACTIVATION GENE-3) (HUMAN-MUS MUSCULUS MONOCLONAL C88 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL C88 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS LAG3 (LYMPHOCYTE ACTIVATING 3, LYMPHOCYTE-ACTIVATION 3, CD223)), HUMANIZED MONOCLONAL ANTIBODY; GAMMA4 HEAVY CHAIN HUMANIZED (1-446) (VH (HOMO SAPIENS IGHV1-58*01 (85.6%) -(IGHD) -IGHJ1*01 (91.7%)) (8.8.12) (1-119) -HOMO SAPIENS IGHG4*01 (CH1 (120-217), HINGE 1-12 (218-229), CH2 (230-339), CH3 (340-444), CHS (445-446)) (120-446)), (133- 218')-DISULFIDE WITH KAPPA LIGHT CHAIN HUMANIZED (1'- 218') (V-KAPPA (HOMO SAPIENS IGKV2D-29*01 (82.0%) -IGKJ4*01 (100%))(10.3.9) (1'-111') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (157), V101 (195) (112'-218')); DIMER (225-225'':228-228'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, GLYCOFORM ALFA
MAVEZELIMAB
MK4280
MK-4280
英文物质名称,关联名称搜索 高级检索
©2006-2026 Drugfuture->FDA Global Substance Registration System